Open, single-arm, single-center evaluation of radiotherapy combined with PD1 antibody plus GM-CSF for microsatellite stabilized colorectal cancer phase II clinical study
Ontology highlight
ABSTRACT: Interventions: Experimental group:GM-CSF + PD-1 antibody + radiotherapy
Primary outcome(s): ORR (Objective Response Rate)
Study Design: Single arm
DISEASE(S): Colorectal Cancer
PROVIDER: 35451 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA